Berman, Elaine S. (1999) ‘Too Little Bone: The Medicalization of Osteoporosis’ , Journal of Woman’s Health and Law1: 257–277 .
2.
Biagioli, Mario (1999) ‘Aporias of Scientific Authorship: Credit and Responsibility in Contemporary Biomedicine’, in Mario Biagioli (ed.), The Science Studies Reader ( New York: Routledge ): 12–30.
3.
Conrad, P. & D. Potter (2000) ‘From Hyperactive Children to ADHD Adults: Observations on the Expansion of Medical Categories’ , Social Problems47: 559–582 .
4.
Dumit, Joseph (2003) ‘A Pharmaceutical Grammar: Drugs for Life and Direct-to-Consumer Advertising in an Era of Surplus Health’, unpublished manuscript, Department of Science, Technology and Society, MIT, Cambridge, MA.
5.
Fishman, Jennifer (2004) ‘Manufacturing Desire: The Commodification of Female Sexual Dysfunction’ , Social Studies of Science34(2): 187–218 .
6.
Foucault, Michel (1984 [1969]) ‘What is an Author?’ in Paul Rabinow (ed.), The Foucault Reader ( New York: Pantheon ): 101–120.
7.
Glenmullen, Joseph (2000) Prozac Backlash ( New York: Simon & Schuster ).
8.
Gomart, Emilie (2002) ‘Methadone: Six Effects in Search of a Substance’ , Social Studies of Science32(1): 93–135 .
9.
Greene, Jeremy (2004) ‘Attention to “Details”: Etiquette and the Pharmaceutical Salesmen in Postwar USA’ , Social Studies of Science34(2): 271–292 .
10.
Healy, David (1998) The Antidepressant Era ( Cambridge, MA: Harvard University Press ).
11.
Healy, David (2004) ‘Shaping the Intimate: Influences on the Experience of Everyday Nerves’ , Social Studies of Science34(2): 219–245 .
12.
Lakoff, Andrew (2004) ‘The Anxieties of Globalization: Antidepressant Sales and Economic Crisis in Argentina’ , Social Studies of Science34(2): 247–269 .
13.
Liebenau, Jonathan (1987) Medical Science and Medical Industry: The Formation of the American Pharmaceutical Industry ( London: Macmillan Press ).
14.
Mahoney, Tom (1959) The Merchants of Life: An Account of the American Pharmaceutical Industry ( New York: Harper & Brothers ).
15.
Metzl, Jonathan (2003) Prozac on the Couch: Prescribing Gender in the Era of Wonder Drugs ( Durham, NC: Duke University Press ).
16.
Parascandola, John (1992) The Development of American Pharmacology ( Baltimore, MD: Johns Hopkins University Press ).
17.
Peppin, Patricia & Elaine Carty (2001) ‘Innovation, Myths and Equality: Constructing Drug Knowledge in Research and Advertising’ , Sydney Law Review23: 543–576 .
18.
Rasmussen, Nicolas (2004) ‘The Moral Economy of the Drug Company–Medical Scientist Collaboration in Interwar America’ , Social Studies of Science34(2): 161–185 .
19.
Segal, Judy (2001) ‘Problems of Genrelization: The Case of the Doctor–Patient Interview’, in Richard M. Coe, Lorelai Lingard and Tatiana Teslenko (eds), The Rhetoric and Ideology of Genre: Problems of Stability and Change ( Cresskill, NJ: Hampton Press ): 171–184.
20.
Smith, Mickey E., E.M. Mick Kolassa, Greg Perkins & Bruce Siecker (eds) (2002) Pharmaceutical Marketing: Principles, Environment and Practice ( Jackson, MO: Pharmaceutical Products Press ).
21.
Swann, John P. (1988) Academic Scientists and the Pharmaceutical Industry ( Baltimore, MD: Johns Hopkins University Press ).
22.
Tiefer, Leonore (2000) ‘Sexology and the Pharmaceutical Industry: The Threat of Cooptation’ , Journal of Sex Research37: 273–283 .
23.
Toronto Globe and Mail (2003) ‘Biovail Drug Campaign Causes Dilemma in U.S.’ (22 July): B1-B1, B21-B21 .
